Design and implementation of software for automated quality control and data analysis for a complex LC/MS/MS assay for urine opiates and metabolites

被引:11
作者
Dickerson, Jane A. [1 ]
Schmeling, Michael [1 ]
Hoofnagle, Andrew N. [1 ,2 ]
Hoffman, Noah G. [1 ]
机构
[1] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA
[2] Univ Washington, Dept Med, Seattle, WA 98195 USA
关键词
Mass spectrometry; Software; Drugs of abuse; Quality assurance; Error reduction;
D O I
10.1016/j.cca.2012.10.055
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Mass spectrometry provides a powerful platform for performing quantitative, multiplexed assays in the clinical laboratory, but at the cost of increased complexity of analysis and quality assurance calculations compared to other methodologies. Methods: Here we describe the design and implementation of a software application that performs quality control calculations for a complex, multiplexed, mass spectrometric analysis of opioids and opioid metabolites. Results: The development and implementation of this application improved our data analysis and quality assurance processes in several ways. First, use of the software significantly improved the procedural consistency for performing quality control calculations. Second, it reduced the amount of time technologists spent preparing and reviewing the data, saving on average over four hours per run, and in some cases improving turnaround time by a day. Third, it provides a mechanism for coupling procedural and software changes with the results of each analysis. We describe several key details of the implementation including the use of version control software and automated unit tests. Conclusions: These generally useful software engineering principles should be considered for any software development project in the clinical lab. (c) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:290 / 294
页数:5
相关论文
共 5 条
[1]   Improved Detection of Opioid Use in Chronic Pain Patients through Monitoring of Opioid Glucuronides in Urine [J].
Dickerson, Jane A. ;
Laha, Thomas J. ;
Pagano, Monica B. ;
O'Donnell, Brendan R. ;
Hoofnagle, Andrew N. .
JOURNAL OF ANALYTICAL TOXICOLOGY, 2012, 36 (08) :541-547
[2]   Algorithm for in vitro diagnostic multivariate index assay [J].
Kato, Kikuya .
BREAST CANCER, 2009, 16 (04) :248-251
[3]  
Practice ACOG, 2007, OBSTET GYNECOL, V109, P217
[4]  
Wians F, 2009, LAB MED, V40, P6
[5]   The Road from Discovery to Clinical Diagnostics: Lessons Learned from the First FDA-Cleared In Vitro Diagnostic Multivariate Index Assay of Proteomic Biomarkers [J].
Zhang, Zhen ;
Chan, Daniel W. .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (12) :2995-2999